This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide.View GSK key stats
GlaxoSmithKline PLC - GSK - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates GlaxoSmithKline PLC as a
Buy with a ratings score of B.
Report Snippet: We rate GLAXOSMITHKLINE PLC (GSK) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.